LONG-TERM HEALTH OUTCOMES IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH THE LONG-ACTING INJECTABLE ANTIPSYCHOTIC ARIPIPRAZOLE LAUROXIL FOR 1 YEAR

被引：0
|
作者：
Gasper, S. M. [1 ]
Dingman, S. [1 ]
Wang, M. [1 ]
Roy, B. D. [1 ]
机构：
[1] Alkermes Inc, Waltham, MA USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO58
引用
收藏
页码：S314 / S315
页数：2
相关论文
共 50 条
  • [1] Aripiprazole Lauroxil Pharmacokinetic Profile of This Long-Acting Injectable Antipsychotic in Persons With Schizophrenia
    Hard, Marjie L.
    Mills, Richard J.
    Sadler, Brian M.
    Turncliff, Ryan Z.
    Citrome, Leslie
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (03) : 289 - 295
  • [2] Aripiprazole long-acting injectable formulations for schizophrenia: aripiprazole monohydrate and aripiprazole lauroxil
    Citrome, Leslie
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (02) : 169 - 186
  • [3] Aripiprazole Lauroxil, a Novel Injectable Long-Acting Antipsychotic Treatment for Adults with Schizophrenia: A Comprehensive Review
    Maini, Kunal
    Gould, Haley
    Hicks, Jessica
    Iqbal, Fatima
    Patterson, James, II
    Edinoff, Amber N.
    Cornett, Elyse M.
    Kaye, Adam M.
    Viswanath, Omar
    Urits, Ivan
    Kaye, Alan D.
    [J]. NEUROLOGY INTERNATIONAL, 2021, 13 (03) : 279 - 296
  • [4] Efficacy of Aripiprazole Lauroxil, a New Long-acting Injectable Atypical Antipsychotic, Across Three Geographic Regions
    Hard, Marjie
    Stankovic, Srdjan
    Risinger, Robert
    Bose, Anjana
    Du, Yangchun
    Zummo, Jacqueline
    Corey, Lisa
    Silverman, Bernard
    Ehrich, Elliot
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S359 - S360
  • [5] Long-term Outcomes of Early Use of Long-Acting Injectable Antipsychotics in Schizophrenia
    Fang, Su-Chen
    Huang, Cheng-Yi
    Shao, Yu-Hsuan Joni
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2022, 83 (04)
  • [6] Long-term outcomes of early use of long-acting injectable antipsychotics in schizophrenia
    Shao, Yu-Hsuan Joni
    Fang, Su-Chen
    Huang, Cheng-Yi
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 272 - 273
  • [7] Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia
    Nasrallah, Henry A.
    Aquila, Ralph
    Du, Yangchun
    Stanford, Arielle D.
    Claxton, Amy
    Weiden, Peter J.
    [J]. CNS SPECTRUMS, 2019, 24 (04) : 395 - 403
  • [8] Long-Acting Injectable Aripiprazole (Abilify Maintena) for Schizophrenia
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1415): : 34 - 36
  • [9] Effects of aripiprazole long-acting injectable antipsychotic on hospitalization in recent-onset schizophrenia
    Karlovic, Dalibor
    Silic, Ante
    Crnkovic, Danijel
    Peitl, Vjekoslav
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2021, 36 (02)
  • [10] Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal Dispersion used for initiation of the long-acting antipsychotic aripiprazole lauroxil
    Hard, Marjie L.
    Wehr, Angela
    von Moltke, Lisa
    Du, Yangchun
    Farwick, Sarah
    Walling, David P.
    Sonnenberg, John
    [J]. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2019, 9
12345